Redesigning the AIDS response for long-term impact;Repenser la riposte au sida pour un impact à long terme

Bulletin of the World Health Organization

Volumn 89, Issue 11, 2011, Pages 846-852

  Larson, Heidi J ^a   Bertozzi, Stefano ^b   Piot, Peter ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b BILL AND MELINDA GATES FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CAPACITY BUILDING; EPIDEMIC; HUMAN IMMUNODEFICIENCY VIRUS; LEADERSHIP; SYNERGISM; UNITED NATIONS;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AFRICA; AGE DISTRIBUTION; ARTICLE; BEHAVIOR CHANGE; CAPACITY BUILDING; COMMUNITY CARE; CULTURAL FACTOR; DRUG EFFICACY; EPIDEMIC; GENDER BIAS; HEALTH CARE ACCESS; HEALTH CARE DELIVERY; HEALTH CARE FINANCING; HEALTH CARE MANAGEMENT; HEALTH CARE NEED; HEALTH CARE PLANNING; HEALTH CARE POLICY; HEALTH CARE QUALITY; HEALTH ECONOMICS; HEALTH PROGRAM; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEADERSHIP; LIFE EXPECTANCY; LONG TERM CARE; MEDICAL RESEARCH; MORTALITY; ORGANIZATION AND MANAGEMENT; PANDEMIC; PERFORMANCE MEASUREMENT SYSTEM; SEXUAL ABUSE; SEXUAL BEHAVIOR; UNITED NATIONS; VIRUS TRANSMISSION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; AFRICA SOUTH OF THE SAHARA; ANTI-HIV AGENTS; DECISION MAKING; DISEASE OUTBREAKS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH POLICY; HEALTH PROMOTION; HUMANS; PROGRAM DEVELOPMENT; PUBLIC HEALTH; SOCIAL MARKETING; TIME FACTORS; WORLD HEALTH;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 80055118280     PISSN: 00429686     EISSN: 15640604     Source Type: Journal    
DOI: 10.2471/BLT.11.087114     Document Type: Article

References (45)

1. Bertozzi SM, Martz T, Piot P. The evolving HIV/AIDS response and the urgent tasks ahead. Health Aff (Millwood) 2009;28:1578-90. doi:10.1377/hlthaff.28.6.1578 PMID:19887400
2. Global report: UNAIDS report on the global AIDS epidemic 2010. Geneva: Joint United Nations Programme on HIV/AIDS; 2010. Available from: http://www.unaids.org/globalreport/documents/20101123_GlobalReport_full_en.pd [accessed 26 September 2011].
3. Hogan MC, Foreman KJ, Naghavi M, Ahn SY, Wang M, Makela SM etal. Maternal mortality for 181 countries, 1980-2008: a systematic analysis of progress towards Millennium Development Goal 5. Lancet 2010;375:1609-23. doi:10.1016/S0140-6736(10)60518-1 PMID:20382417
4. Piot P. AIDS: from crisis management to sustained strategic response. Lancet 2006;368:526-30. doi:10.1016/S0140-6736(06)69161-7 PMID:16890840
5. Pneumocystis pneumonia-Los Angeles. MMWR Weekly 1981;30:1-3. Available from: http://www.cdc.gov/mmwr/preview/mmwrhtml/june_5.htm[accessed 17 October 2011]
6. aids2031 (internet site). Available from: www.aids2031.org [accessed 26 September 2011].
7. The aids2031 consortium. AIDS: taking a long-term view. New Jersey: FT Press Science; 2011.
8. Cranston P, Davies T, Kao ATC, Fonseca F, Cumming L, Hazarika M, et al. Future connect: a review of social networking today, tomorrow and beyond and challenges for AIDS communicators. South Orange: Communication for Social Change Consortium. 2009. Available from: http://www.aids2031.org/working-groups/communication [accessed 26 September 2011].
9. Haines A, Wilkinson P, Tonne C, Roberts I. Aligning climate change and public health policies. Lancet 2009;374:2035-8. doi:10.1016/S0140-6736(09)61667-6 PMID:19942274
10. Beaglehole R, Bonita R, Horton R, Adams C, Alleyne G, Asaria P etal. Priority actions for the non-communicable disease crisis. Lancet 2011;377:1438-47. doi:10.1016/S0140-6736(11)60393-0 PMID:21474174
11. World population prospects: the2008 revision. New York: Department of Economic and Social Affairs of the United Nations; 2010.
12. Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N etal. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 2011;365:493-505. doi:10.1056/NEJMoa1105243 PMID:21767103
13. Karim QA, Karim SSA, Frohlich JA, Grobler AC, Baxter C, Mansoor LE etal. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science 2010;329:1168-74. doi:10.1126/science.1193748 PMID:20643915
14. Grant RM, Lama R Jr, Anderson PL, McMahan V, Liu AY, Vargas L etal. Pre-exposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med 2010;363:2587-99. doi:10.1056/NEJMoa1011205 PMID:21091279
15. Pivotal study finds that HIV medications are highly effective as prophylaxis against HIV infection in men and women in Africa [media release]. University of Washington International clinical research center, 13 July 2011. Available from: http://www.hanc.info/Documents/PrEP_PressRelease-UW_13Jul2011.pdf [accessed 26 September 2011].
16. Resolution 1983 (2011). In: 6547th meeting of the United Nations Security Council, New York, 7 June 2011 (S/RES/1983(2011).
17. Political declaration on HIV/AIDS: intensifying our efforts to eliminate AIDS. In: United Nations General Assembly, New York, 10June2011 (A/RES/65/277).
18. Editorial. A strategic revolution in HIV and global health. Lancet 2011;377:2055. doi:10.1016/S0140-6736(11)60901-X PMID:21684364
19. Merson MH. The HIV/AIDS pandemic at 25-the global response. N Engl J Med 2006;354:2414-7. doi:10.1056/NEJMp068074 PMID:16760441
20. Financing the response to AIDS in low-and middle-income countries: international assistance from the G8, European Commission and other donor governments in 2010. Menlo Park: Henry J Kaiser Family Foundation; 2010. Available from: http://www.kff.org/hivaids/7347.cfm [accessed 26 September 2011].
21. Piot P, Russell S, Larson H. Good politics, bad politics: the experience of AIDS. Am J Public Health 2007;97:1934-6. doi:10.2105/AJPH.2007.121418 PMID:17901417
22. Padian NS, McCoy SI, Abdool Karim SS, Hasen N, Kim J, Bartos M etal. HIV prevention transformed: the new prevention research agenda. Lancet 2011;378:269-78. doi:10.1016/S0140-6736(11)60877-5 PMID:21763938
23. Virgin HW, Walker BD. Immunology and the elusive AIDS vaccine. Nature 2010;464:224-31. doi:10.1038/nature08898 PMID:20220841
24. Koff WC. Accelerating HIV vaccine development. Nature 2010;464:161-2. doi:10.1038/464161a PMID:20220821
25. Declaration from the UNAIDS High Level Commission on HIV Prevention. Geneva: Joint United Nations Programme on HIV/AIDS; 2010. Available from: http://www.hivpreventioncommission.com/index.php?q=node/27 [accessed 26 September 2011].
26. Alcorn K, editor. Advancing science and technology to change the future of the AIDS epidemic. Final report of the Science and Technology Working Group. Seattle: Program for Appropriate Technology (PATH); 2010. Available from: http://www.aids2031.org/working-groups/science-and-technology?view=resources#138 [accessed 26 September 2011].
27. Buse K, Dickenson C, Sidibe M. HIV: know your epidemic, act on its politics. J R Soc Med 2008;101:572-3. doi:10.1258/jrsm.2008.08k036 PMID:19092021
28. Piot P, Bartos M, Larson H, Mane P. Coming to terms with complexity: a call to action for HIV prevention. Lancet 2008;372:845-59. doi:10.1016/S0140-6736(08)60888-0 PMID:18687458
29. Dodd PJ, White PJ, Garnett GP. Notions of synergy for combinations of interventions against infectious diseases in heterogeneously mixing populations. Math Biosci 2010;227:94-104. doi:10.1016/j.mbs.2010.06.004 PMID:20600157
30. Soni A, Gupta R. Bridging the resource gap: improving value for money in HIV/AIDS treatment. Health Aff (Millwood) 2009;28:1617-28. doi:10.1377/hlthaff.28.6.1617 PMID:19887403
31. Morris MB, Chapula BT, Chi BH, Mwango A, Chi HF, Mwanza J etal. Use of task-shifting to rapidly scale-up HIV treatment services: experiences from Lusaka, Zambia. BMC Health Serv Res 2009;9:5. doi:10.1186/1472-6963-9-5 PMID:19134202
32. Jaffar S, Amuron B, Foster S, Birungi J, Levin J, Namara G etal. Rates of virological failure in patients treated in a home-based versus a facility-based HIV-care model in Jinja, southeast Uganda: a cluster-randomised equivalence trial. Lancet 2009;374:2080-9. doi:10.1016/S0140-6736(09)61674-3 PMID:19939445
33. Dart Trial Team. Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomized non-inferiority trial. Lancet 2010;375:123-31. doi:10.1016/S0140-6736(09)62067-5 PMID:20004464
34. Treatment 2.0 In: UNAIDS Outlook Report. Geneva: Joint United Nations Programme on HIV/AIDS; 2010:46-53.
35. Auerbach J, Parkhurst JO, Cáceres CM. Addressing social drivers of HIV/AIDS for the long-term response: conceptual and methodological considerations (aids2031 working paper no. 24). Available from: http://www.aids2031.org/working-groups/social-drivers [accessed 26 September 2011].
36. Revolutionizing the AIDS response: building AIDS resilient communities (aids2031 Social Drivers Working Group report). Worcester, MA: Clark University and International Center for Research on Women; 2010. Available from: http://www.aids2031.org/working-groups/social-drivers?view=resources#137 [accessed 26 September 2011].
37. The Vienna Declaration. In: XVIII International AIDS Conference (AIDS 2010), Vienna, 18-23July2010. Available from: http://www.viennadeclaration.com/the-declaration/ [accessed 26 September 2011].
38. Schwartländer B, Stover J, Hallett T, Atun R, Avila C, Gouws C etal. Towards an improved investment approach for an effective response to HIV/AIDS. Lancet 2011;377:2031-41. doi:10.1016/S0140-6736(11)60702-2 PMID:21641026
39. Health systems strengthening. In: PEPFAR's contributions to the Global Health Initiative. Washington: The United States President's Emergency Plan for AIDS Relief; 2009. Available from: http://www.pepfar.gov/strategy/ghi/134854.htm [accessed 26 September 2011].
40. Health systems strengthening. Geneva: The Global Fund to Fight AIDS, Tuberculosis and Malaria; 2011. Available from: http://www.theglobalfund.org/en/performance/effectiveness/hss/ [accessed 26 September 2011].
41. Verma R, Shekhar A, Khobragade S, Adhikary R, George B, Ramesh BM et al. Scale-up and coverage of Avahan: a large-scale HIV-prevention programme among female sex workers and men who have sex with men in four Indian states. Sex Transm Infect 2010;86(suppl 1):i76-82. doi:10.1136/sti.2009.039115 PMID:20167737
42. Ruiz M. Are you experienced? Using the latest lessons learned from marketing research on consumer experience to improve the research and development of new HIV prevention technologies (aids2031 Working Paper no. 9). Available from: http://www.aids2031.org/pdfs/aids2031%20preconf%20reading%20-%20are%20you%20experienced%20_ruiz.pdf [accessed 26 September 2011].
43. US and world leaders commit to elimination of mother-to-child HIV transmission (media release). United States Mission to the United Nations and other international organizations in Geneva, 9 June 2011. Available from: http://geneva.usmission.gov/2011/06/10/u-s-and-world-leaders-commit-to-elimination-of-mother-to-child-hiv-transmission/ [accessed 26 September 2011].
44. Institute of Medicine. Preparing for the future of HIV/AIDS in Africa: a shared responsibility. Washington: National Academies Press; 2011.
45. Gray RH, Waiver MJ. Reassessing the hypothesis of STI control for prevention. Lancet 2008;371:2064-5. doi:10.1016/S0140-6736(08)60896-X PMID:18572064